Admera Health is an advanced molecular diagnostics company focused on personalized medicine and non-invasive cancer testing. We are committed to improving the health and well-being of our global community. Using Next Generation Sequencing (NGS), Admera Health is redefining the standard of care for patients in all fields of medicine. Learn More
Developing tests covering prominent diseases that span the continuum of care. Current products include PGxOne™ Plus, CardioGxOne™, OncoGxOne™, and OncoGxSelect™.Learn More
Our new product pipeline significantly advances personalized medicine by applying next generation technologies to non-invasive cancer testing and digital health. Keep checking back here periodically as we are continuously updating content and product information.

Learn More